Clinical Trials Browser

Fallopian Tube Neoplasms, Ovarian Neoplasms

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Neoplasm Metastasis

Urinary Bladder Neoplasms

Liver Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Urinary Bladder Neoplasms

Phase 2 Study

Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease

Metastatic Urothelial Cancer

Breast Neoplasms

Urinary Bladder Neoplasms

Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Urinary Bladder Neoplasms

Advanced Solid Tumour

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

Hodgkin Disease

Pancreatic Neoplasms

Lymphoma, Large B-Cell, Diffuse

Infiltrating Bladder Urothelial Carcinoma

Rhabdoid Tumor

Pancreatic Neoplasms

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Urinary Bladder Neoplasms

Triple Negative Breast Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Adenocarcinoma, Carcinoma, Pancreatic Ductal

Lung Neoplasms

Lung Diseases, Interstitial

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

Advanced Squamous Non-Small Cell Lung Cancer

Advanced Biliary Tract Carcinoma

Biliary Tract Neoplasms, Stomach Neoplasms

Breast Neoplasms

Pancreatic Neoplasms

Biliary Tract Neoplasms

Advanced Cancer

Locally Advanced or Metastatic Solid Tumours

Neoplasm Metastasis, Triple Negative Breast Neoplasms

Hodgkin Disease

Urinary Bladder Neoplasms

Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Advanced Biliary Tract Cancer(BTC)

Pancreatic Neoplasms

Lymphoma, Large B-Cell, Diffuse

Pancreatic Neoplasms

Clinical Trials

Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymphoma

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

TROPHY U-01

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

TRIFECTA

A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

MK-3475-01E

HOVON164HL

PANCREAS

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Intravesical Gem/Doce in Patients With NMIBC

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

CECYDE

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

ZN-c3 + Gemcitabine in Pancreatic Cancer

DVDMS

RP-6306 in Patients With Advanced Cancer

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

ToPCourT

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

NOBLE

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer